Experimental eye drops aim to target genetic cause of blinding corneal disease
NCT ID NCT07024693
Summary
This study is testing an experimental eye drop called DT-168 in patients with Fuchs Endothelial Corneal Dystrophy (FECD), a genetic eye disease that can cause vision loss and often requires a corneal transplant. The main goal is to see if the drops can affect the underlying genetic problem in the eye and to check if they are safe and well-tolerated. The study will enroll 28 patients who are already scheduled for a transplant, allowing researchers to examine the treated eye tissue after surgery.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for FUCHS ENDOTHELIAL CORNEAL DYSTROPHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
DTX-168-201 Study Site
RECRUITINGIndianapolis, Indiana, 46260, United States
-
DTX-168-201 Study Site
RECRUITINGGrand Rapids, Michigan, 49546, United States
Conditions
Explore the condition pages connected to this study.